Zentalis Pharmaceuticals shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Zentalis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Zentalis Pharmaceuticals held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Zentalis Pharmaceuticals by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $22k | 5.8k | 3.68 |
| 2024-06-30 | $24k | 5.8k | 4.09 |
| 2024-03-31 | $92k | 5.8k | 15.76 |
| 2023-12-31 | $88k | 5.8k | 15.15 |
| 2023-09-30 | $117k | 5.8k | 20.06 |
| 2023-06-30 | $114k | 4.1k | 28.21 |
| 2023-03-31 | $63k | 3.7k | 17.20 |
| 2022-12-31 | $85k | 3.7k | 22.99 |
| 2022-09-30 | $79k | 3.7k | 21.46 |
| 2022-06-30 | $77k | 2.8k | 27.98 |
| 2022-03-31 | $127k | 2.8k | 46.15 |
| 2021-12-31 | $231k | 2.8k | 83.94 |
| 2021-09-30 | $183k | 2.8k | 66.50 |
| 2021-06-30 | $139k | 2.6k | 53.32 |
| 2021-03-31 | $104k | 2.4k | 43.19 |
| 2020-12-31 | $125k | 2.4k | 51.91 |
| 2020-09-30 | $30k | 913 | 32.86 |
| 2020-06-30 | $44k | 913 | 48.19 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors